DAXX expression was found significantly lower in colorectal carcinoma (CRC) cases with positive serum carcinoembryonic antigen (CEA) screening results (defined as serum CEA levels of >5 ng/mL) compared to patients with negative CEA screening levels. This evidence concerns the gene CEACAM5 and colorectal carcinoma.